Implantable medical interventional device with shifting zones of tachycardia recognition and therapy

• US 5,458,622 A
• Filed: 07/11/1994
• Issued: 10/17/1995
• Est. Priority Date: 04/03/1992
• Status: Expired due to Term

• Current Assignee: Intermedics Incorporated
• Original Assignee: Intermedics Incorporated
• Inventors: Alt, Eckhard
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US08/273,478
• Time in Patent Office: 463 Days
• Field of Search: 607/15, 607/17, 607/19
• US Class Current: 607/15
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/395 for treating atrial fibrillation
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A device-implemented method detects and treats abnormal (i.e., pathologic) tachycardias experienced by a patient with an implanted automatic defibrillator. The defibrillator has the capability to distinguish pathologic tachycardia from physiologic tachycardia by the application of predetermined distinction criteria programmed into it. Changes in a physiologic parameter of the patient which signify a physiologic basis for increase or decrease of the patient'"'"'s heart rate are detected, and in response, the distinction criteria are modified to enhance the capability of the defibrillator to make the distinction between pathologic and physiologic tachycardia when this change in circumstances that would otherwise tend to obscure the distinction is factored in. In one method, the parameter under detection is patient activity, and the distinction criteria include a threshold heart rate above which the patient is presumed to be experiencing a pathologic tachycardia. The threshold rate is shifted up or down depending on whether the detected change is indicative of an increase or a decrease, respectively, of the patient'"'"'s heart rate.

Claims

1. A method for determining which therapy in a tier of electrical therapies is to be applied to the heart of a cardiac patient to treat pathologic tachycardia, the method including the steps of establishing different zones for recognizing and distinguishing pathologic tachycardia from physiologic tachycardia, sensing the status of a physiologic parameter of the patient other than the patient'"'"'s ECG, shifting the different zones upwardly or downwardly in response to the status of said physiologic parameter other than ECG, and correspondingly shifting the therapies in said tier to be applied to the patient'"'"'s heart upwardly or downwardly in response to said status, whereby to avoid treating a detected tachycardia that is purely physiologic with the therapies.

2. The method of claim 1, in which the step of sensing the status of a physiologic parameter other than ECG is sensing patient activity.

3. An implantable medical interventional device for delivering any of a plurality of different electrical therapies to the heart of an implant patient to treat pathologic tachycardia, comprising:

first sensor means for generating a signal indicative of the patient'"'"'s cardiac activity,

second sensor means for generating a signal representative of the current status of physical activity or lack of physical activity by the patient,

programmable evaluating means for establishing a tier of said plurality of therapies including multiple zones of successively higher threshold rate bounded by respective successively higher upper and lower heart rates to detect a tachycardia from the cardiac activity signal generated by said first sensor means and to distinguish whether the detected tachycardia is pathologic or physiologic in each of said zones, whereby to avoid treating a detected tachycardia that is purely physiologic with said therapies, said programmable evaluating means including comparing means for comparing the rate of the detected tachycardia to the threshold rate in each of said zones, and

control means for shifting upwardly or downwardly through said tier of therapies in response to sensing respective increases or decreases in the rate of a pathologic tachycardia in said cardiac activity signal based on the comparisons with respective threshold rates and on the physical activity status signal generated by said second sensor means, so that the particular one of said therapies within said tier selected to treat the pathologic tachycardia is highly dependent on whether the tachycardia is accelerating or decelerating.

4. The device of claim 3, in which:

the second sensor means comprises a sensor of physical movement.

5. The device of claim 3, in which:

the activity sensor is an accelerometer.

6. The device of claim 5, in which:

said control means includes means for designating successively more aggressive therapies as the lowest therapies available in the respective rate zones until the pathologic tachycardia is broken.

7. The device of claim 3, in which:

said control means includes means for shifting upwardly or downwardly through said tier when the signal generated by the second sensor means indicates a change from patient rest to patient exercise, and for shifting the boundary heart rate to a lower rate when the signal generated by the second sensor means indicates a change from patient exercise to patient rest.

8. The device of claim 7, in which:

said control means includes means for shifting said boundary heart rate to a lower rate comprising the original boundary heart rate.

9. The device of claim 7, in which:

the second sensor means is an accelerometer.

10. A method for detecting pathologic tachycardia to determine when to deliver electrical therapy to the heart of a cardiac patient to treat the pathologic tachycardia, comprising the steps of:

establishing different zones of heart rate recognition,

setting criteria to be applied for evaluating an ECG signal indicative of the patient'"'"'s cardiac activity to recognize onset and continued existence of pathologic tachycardia in the different zones of heart rate recognition,

changing the criteria according to a signal indicating the status of patient activity,

the electrical therapy being tiered according to the different zones of heart rate recognition,

applying increasingly aggressive therapies with either continuance or acceleration of the pathologic tachycardia, and

shifting the zones of heart rate recognition, and consequent therapies to be applied, up or down depending upon the activity signal.

11. The method of claim 10, in which the step of changing the criteria includes determining whether the signal indicates that patient is resting or active, and if active, the approximate level of activity.

12. The method of claim 10, in which the step of changing the criteria includes shifting a criterion representative of the patient'"'"'s heart rate among said criteria, said criterion indicative of pathologic tachycardia being shifted up or down depending on whether the activity signal indicates increased or decreased patient activity, respectively.

13. The method of claim 10, in which the step of changing the criteria includes shifting a criterion representative of the patient'"'"'s heart rate among said criteria, said criterion indicative of pathologic tachycardia being shifted to higher values with commencement and increases of physical activity by the patient and to lower values with decreases and cessation of physical activity by the patient.